# Safety and Efficacy Study of APD125 in Patient With Insomnia

> **NCT00452179** · PHASE2 · COMPLETED · sponsor: **Arena Pharmaceuticals** · enrollment: 173 (actual)

## Conditions studied

- Insomnia

## Interventions

- **DRUG:** APD125

## Key facts

- **NCT ID:** NCT00452179
- **Lead sponsor:** Arena Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2007-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00452179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00452179, "Safety and Efficacy Study of APD125 in Patient With Insomnia". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00452179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*